6-K

Sofgen Pharma S.A. (PROCF)

6-K 2024-10-08 For: 2024-10-08
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 6-K



REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934


For the month of October 2024

Commission File Number: 001-40851


Procaps Group, S.A.

(Translation of registrant’s namein English)

9 rue de Bitbourg, L-1273

Luxembourg

Grand Duchy of Luxembourg

R.C.S. Luxembourg: B253360

Tel : +356 7995-6138

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

INFORMATION CONTAINED INTHIS REPORT ON FORM 6-K

Resignation of Director


On October 8, 2024, Mr. Ruben Minski resigned from the Board of Directors (the “Board”) of Procaps Group, S.A., a public limited liability company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg (the “Company”), effective immediately. The Board is considering and evaluating a successor to Mr. Ruben Minski.

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PROCAPS GROUP, S.A.
By: /s/ José Antonio Toledo Vieira
Name: José Antonio Toledo Vieira
Title: Chief Executive Officer

Dated: October 8, 2024